FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis

BSE588.2011.4 (+1.98 %)

PREV CLOSE (Rs.) 576.80

OPEN PRICE (Rs.) 584.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 24968

TODAY'S LOW / HIGH (Rs.)582.55 601.45

52 WK LOW / HIGH (Rs.)413 608.95

NSE588.4511.55 (+2 %)

PREV CLOSE( Rs. ) 576.90

OPEN PRICE (Rs.) 583.15

BID PRICE (QTY) 588.45 (94)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 687298

TODAY'S LOW / HIGH(Rs.) 581.25 602.00

52 WK LOW / HIGH (Rs.)412.25 609.05

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

147.52

Dividend Yield(%)

0.85

TTM EPS (Rs.)

8.32

P/E Ratio

70.68

Book Value (Rs.)

68.90

Face Value (Rs.)

MCap (Rs. in Mn)

121985.37

Price/Earning (TTM)

42.25

Price/Sales (TTM)

8.62

Price/Book (MRQ)

8.54

PAT Margin (%)

11.51

ROCE (%)

17.77

Incorporation Year : 10-11 2000

Management Info :

Ameera Shah - Chairman Surendran Chemmenkotil - Managing Director

Registered Office :

Address : 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone : 022 6258 2810 / 8422 801 801

Email : support@metropolisindia.com / secretarial@metropolisindia.com

Website : www.metropolisindia.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

23Mar Metropolis Healthcare informs about al
In reference to its previous intimations dated February 04, 2026, March..

31Jan Metropolis Healthcare informs about bo
Metropolis Healthcare has informed that the meeting of the Board of Dire..

13Jan Metropolis Healthcare informs about pr
Metropolis Healthcare has informed that it attached copy of the Press Re..

Financials

	QTR Jun 26	ANNUAL 26
Net Profit	505.83	1574.83
Gross Profit	663.76	2112.43
Operating Profit	989.55	3545.54
Net Sales	3722.84	13654.72

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hosp (BSE)

5224.95 (0.93%)

M.Cap (Rs. in Cr)2525.13

Apollo Hospital Ent. (BSE)

8845.70 (0.46%)

M.Cap (Rs. in Cr)127187.59

Narayana Hrudayalay. (BSE)

1931.65 (1.45%)

M.Cap (Rs. in Cr)39475.35

Fortis Healthcare (BSE)

930.00 (1.51%)

M.Cap (Rs. in Cr)70211.11

Shareholding Pattern

	PROMOTERS	48.86%
	MUTUAL FUNDS/UTI	32.67%
	NON-INSTITUTION	4.99%
	FI/BANKS/INSURANCE	2.05%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

NJ ELSS Tax Saver S...

3.86

Tata India Pharma &...

2.42

HDFC Pharma and Hea...

2.35

LIC MF Healthcare F...

2.22

Tata Focused Fund-Reg(G)

2.06

JM Aggressive Hybri...

1.98

Tata Business Cycle...

1.80

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

METROPOLIS HEALTHCARE LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives